Financhill
Back

Atlanta Braves Holdings, Inc. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
58

BATRK
Atlanta Braves Holdings, Inc.

Last Price:
$43.86
Seasonality Move:
2.12%
Buy
100

ORKA
Oruka Therapeutics, Inc.

Last Price:
$53.39
Seasonality Move:
5.42%
Buy
58
Atlanta Braves Holdings, Inc. (BATRK) is a Buy

Is Atlanta Braves Holdings, Inc. a Buy, Sell or Hold?

  • The current Atlanta Braves Holdings, Inc. [BATRK] share price is $43.89. The Score for BATRK is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • BATRK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
100
Oruka Therapeutics, Inc. (ORKA) is a Buy

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $53.31. The Score for ORKA is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • ORKA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

BATRK Stock Price Chart

What is Atlanta Braves Holdings, Inc.'s stock price today?

  • The Atlanta Braves Holdings, Inc. share price today is $43.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BATRK is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $53.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing buying pressure, which is a positive indicator for future bullish movement.

BATRK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 60.18 Buy
Chaikin Money Flow: 239402 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.21 - 43.75) Buy
Bollinger Bands (100): (38.83 - 42.53) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.1 Buy
Relative Strength Index (14 RSI): 77.59 Buy
Chaikin Money Flow: 1458349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.68 - 45.6) Buy
Bollinger Bands (100): (27.9 - 38.44) Buy

BATRK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.45 Buy
20-day SMA: 42.78 Buy
50-day SMA: 42.06 Buy
200-day SMA: 41.94 Buy
8-day EMA: 42.67 Buy
20-day EMA: 42.64 Buy
50-day EMA: 42.13 Buy
200-day EMA: 41.28 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Buy
20-day SMA: 41.09 Buy
50-day SMA: 36.64 Buy
200-day SMA: 25.3 Buy
8-day EMA: 47.34 Buy
20-day EMA: 42.69 Buy
50-day EMA: 37.82 Buy
200-day EMA: 28.4 Buy

Atlanta Braves Holdings, Inc. Earnings Growth & BATRK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.84 per share, a decrease next quarter of $1.92 per share, an increase this year of $0.02 per share, and an increase next year of $0.34 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.31 per share.

Atlanta Braves Holdings, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):